BlackRock Health Sciences Opportunities Portfolio Class K SHSKX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 73.93  /  −0.09 %
  • Total Assets 6.2B
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Below Average
  • Share Class Type Retirement, Large
  • Category Health
  • Investment Style Large Value
  • Min. Initial Investment 5M
  • Status Open
  • TTM Yield 0.40%
  • Turnover 43%

USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:35 AM GMT+0

Morningstar’s Analysis SHSKX

Will SHSKX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BlackRock Health Sciences Opps K holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHSKX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 51.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.29 726M
Healthcare

Johnson & Johnson

7.96 470M
Healthcare

UnitedHealth Group Inc

6.10 360M
Healthcare

Merck & Co Inc

4.94 292M
Healthcare

Gilead Sciences Inc

4.19 248M
Healthcare

AbbVie Inc

3.94 233M
Healthcare

Amgen Inc

3.37 199M
Healthcare

Thermo Fisher Scientific Inc

3.02 178M
Healthcare

Vertex Pharmaceuticals Inc

2.74 162M
Healthcare

Pfizer Inc

2.61 154M
Healthcare

Sponsor Center